Scholarly Works - Conferences
Conference
Eur J Heart Fail
·
August 2025
AIMS: Whether prior treatment with angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs) modifies efficacy and safety of sacubitril/valsartan (Sac/Val) in patients with heart failure (HF) and ejection fraction (EF) >40% is ...
Full text
Link to item
Cite
Conference
Journal of Clinical Oncology
·
May 20, 2021
e18861 Background: Low -value care contributes to the high costs of cancer treatment. Almost a decade has passed since the American Society of Clinical Oncology (ASCO) Choosing Wisely campaign identified costly diagnostic testing ...
Full text
Cite